the timelines on predicted events don't read well on reflection.
we have presented our covid rat so IMO any new product would have to be our multiplex test. from our last quarterly
"At the end of March, the initial manufacturing transfer process to Operon was completed, with the first small batch runs to occur in April."
"Once consistent manufacturing runs are achieved which pass all internal Quality Control (QC) processes, AnteoTech will then produce commercially manufactured lots for the purposes of clinical trials. Discussions with CROs to facilitate the trials have begun, with commencement of the clinical trials once manufacturing processes have been finalised and technology transfer successfully completed."
who knows how far the multiplex test has advanced. it would be good to hear some news and just maybe we could be surprised with the upside of advancements??? GLTAH
ADO Price at posting:
8.4¢ Sentiment: Hold Disclosure: Held
